ViewRay, Inc

VRAY NASDAQ

LeLaf

Price Target = 12.44$

KozakHlib

Contextual immersion trading strategy idea. ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The demand for shares of the company still looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $5.44; stop-loss — $4.95. Information about...

theimpeccableinvestor

Description: VRAY is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position. Stats: 1. Ideal buy range: $4.4 - $4.8 2. Take profit: $6.33 3. Stop Loss: $3.98 4. Risk To Reward: 1 / 5 5. Accuracy Rating: 91%

topski

$VRAY Cup & Handle pattern forming. With a 7.85% short float and 5.25 days to cover I would expect a large spike in the next few days to finish off this pattern.

scorpioidk

TP is $10

MillennialInvestmentsPros

BREAKOUT STOCK ALERT $VRAY - ViewRay, Inc. - Common Stock Initial Alert Price: $5.1 Potential Price: $5.96 Potential Gains: 16.86 Stop Loss Limit: $ VRAY is currently showing signals to retest the $5.96 Price Levels providing an investment in the trade today with a potential 15-20% gain on the investment over the course of the next few weeks. If the stock is...

justimm

Holding support at 50MA with crossing the Golden Cross. Medical Oncology technology with Very bright Future. Filled the gap and retesting. Short term goal 6.6 and long term > 9 and beyond. Stock to own it.

GuyInHat

Needs to hold this level. MACD looks great for a reversal. We have HBD on MACD and RSI for both 4h and Daily. Did just confirm on the 4 hr too. This support level is also a historical resistance.

ai-bots-trade

This one looks like its going hit the support line at $4.15 as it follows the triangle pattern, but if it breaks it there should be another strong move down under $4.00 with all the room in the RSI. STOP LOSS $5.40 TAKE PROFIT < $4.16

Vibranium_Capital

rejected at trendline resistance and going lower, but if this little trend its been holding lately continues, the dip entry is soon... my idea is wait for 4.5 entry stop loss 3.5 price target 7 ! great risk reward entry if you wait for a little more dip action! leave a like and follow :)

vedatttt

Future time price.. Just wait

Benji-13

CLEVELAND, Ohio, Jan. 4, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2020. The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full Year 2020 Preliminary Results and Other Data (Unaudited): Total revenue of...

JMETZLER1

VRAY seems to be staying within this channel. Should I consider a long position in expectation of a positive move out of the pattern toward the end of August? Asking as a newb. Not advice.Happy trading.

DigitalData

Keep this one on your watchlist we are getting close :)

SMFinders

Provided two days ago in the Pro PAckage! Hi members! The SMF strategy forecast indicates a setup on the following Stock; Symbol Name : VRAY Stock : VIEWRAY INC Exchange : NASDAQ Sector : Health Technology Insdustry : Medical Specialities Term : Short SMF strategy would be to Buy : Between : $1.98 – 2.02 SMF strategy would be to Sell at : Short...

ccarlos02

Don't have much time trading but it seems like the price is making higher highs but RSI is making lower highs which could signal a reversal, also has higher lows but RSI shows lower lows. Any feedback would be great thank you!!!

CryptoPaily

VRAY has been on a downtrend this whole year however there has been significant buying activity lately. The weekly MACD is about to turn bullish while the RSI has just had a higher low and is trying to come out of oversold territory. Currently VRAY is close to its 52 week low price. There has been large buying activity from the insiders, CEO, CSO (chief...

PennyStock101

ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical...